The ViroSeq™ HIV-1 genotyping system is an FDA-cleared DNA sequencing based assay that is designed to identify mutations in the protease and reverse transcriptase regions of the human immunodeficiency virus (HIV-1) that are associated with drug resistance. Accurate sequence is achieved through overlapping sequenced regions. This system accommodates a variety of throughput needs and levels of automation. The ViroSeq HIV-1 genotyping system v2.6 report can identify mutations to 19 different drugs and is cleared for use on the ABI PRISM‚ 3100 genetic analyzer and the ABI PRISM‚ 3700 DNA sequencer.

Abbott Laboratories
(800) 323-9100; www.abbottdiagnostics.com